학술논문
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
Document Type
Article
Author
Source
In: Blood . (Blood, 6 April 2023, 141(14):1675-1684)
Subject
Language
English
ISSN
15280020
00064971
00064971